Gene Therapy for Alzheimer's Disease Clinical Trial

Completed · Phase 1

Conditions studied: Alzheimer Disease

In brief

This Phase I clinical trial is the first step in testing gene therapy. This study is called a "Safety/Toxicity" study by the Food and Drug Administration, and primarily aims to determine whether the experimental protocol is safe for humans. It will determine whether the study procedure causes side effects in humans, and may also give us a preliminary sense of whether this will be effective in combating Alzheimer's disease in humans.

Key facts

Study ID

NCT00017940

Run by

The Shiley Family Trust

People needed

8

Expected to finish

2003-11-01

Last updated by the study team

2009-12-11

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of California, San Diego, ADRC — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.